This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (19)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Aging/ Geriatrics  • Macular Degeneration  • Genetics  • Genetic Disorders  • Alert me on articles by topic  Social Bookmarking   What's this?

R. Keith Shuler Jr, MD; Michael A. Hauser, PhD; Jennifer Caldwell, COA; Paul Gallins, MS; Silke Schmidt, PhD; William K. Scott, PhD; Anita Agarwal, MD; Jonathan L. Haines, PhD; Margaret A. Pericak-Vance, PhD; Eric A. Postel, MD

Arch Ophthalmol. 2007;125(1):63-67.

Objective  To compare phenotypes of 2 age-related macular degeneration (AMD) susceptibility genes: LOC387715 and complement factor H (CFH).

Methods  Phenotypes of 755 AMD cases were characterized. The number of LOC387715 (T allele at rs10490924, or A69S) and CFH (T1277C at rs1061170, or Y402H) risk alleles were determined in each case. Individuals were divided into 5 groups by genotype: group 1, LOC–/– CFH–/–; group 2, LOC+/– CFH–/– or LOC+/+ CFH–/–; group 3, LOC–/– CFH+/– or LOC–/– CFH+/+; group 4, LOC+/– CFH+/–, LOC+/+ CFH+/–, or LOC+/– CFH+/+; and group 5, LOC+/+ CFH+/+.

Results  Signs of neovascular AMD including grade (P = .002), pigment epithelial detachment (P = .001), and subretinal hemorrhage (P<.001) demonstrated significant association with groups 2, 4, and 5 vs groups 1 and 3. Group 5 had a significantly younger mean age (72.3 years) compared with other groups (P = .002).

Conclusions  The AMD cases possessing the LOC387715 (rs10490924) variant may have a higher risk of neovascular AMD. Individuals with AMD who are homozygous for both variants might be at greater risk for earlier onset of neovascular AMD.

Author Affiliations: Eye Center (Drs Shuler and Postel and Ms Caldwell) and Center for Human Genetics (Drs Hauser, Schmidt, Scott, and Pericak-Vance and Mr Gallins), Duke University, Durham, NC; and Eye Institute (Dr Agarwal) and Medical Center, Center for Human Genetics Research (Dr Haines), Vanderbilt University, Nashville, Tenn.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Complement Factor H and the Bilaterality of Age-Related Macular Degeneration: The Blue Mountains Eye Study
Pai et al.
Arch Ophthalmol 2009;127:1339-1344.
ABSTRACT | FULL TEXT  

Analysis of Major Alleles Associated With Age-Related Macular Degeneration in Patients With Multifocal Choroiditis: Strong Association With Complement Factor H
Ferrara et al.
Arch Ophthalmol 2008;126:1562-1566.
ABSTRACT | FULL TEXT  

Genotype-Phenotype Correlations for Exudative Age-Related Macular Degeneration Associated with Homozygous HTRA1 and CFH Genotypes
Leveziel et al.
IOVS 2008;49:3090-3094.
ABSTRACT | FULL TEXT  

Variants in the 10q26 Gene Cluster (LOC387715 and HTRA1) Exhibit Enhanced Risk of Age-Related Macular Degeneration along with CFH in Indian Patients
Kaur et al.
IOVS 2008;49:1771-1776.
ABSTRACT | FULL TEXT  

Genotype-phenotype correlation of age-related macular degeneration: influence of complement factor H polymorphism
Droz et al.
Br J Ophthalmol 2008;92:513-517.
ABSTRACT | FULL TEXT  

Genetic susceptibility to age-related macular degeneration: a paradigm for dissecting complex disease traits
Swaroop et al.
Hum Mol Genet 2007;16:R174-R182.
ABSTRACT | FULL TEXT  

Genetic Ophthalmology and the Era of Clinical Care
Sieving and Collins
JAMA 2007;297:733-736.
FULL TEXT  

Ophthalmic Genetics: At the Dawn of Discovery
Hyman et al.
Arch Ophthalmol 2007;125:9-10.
FULL TEXT